Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic potential of cannabinoids.

Literature DB >> 6803904

Therapeutic potential of cannabinoids.

D N Bateman, M D Rawlins.

Abstract

Mesh：

Substances：

Year: 1982 PMID： 6803904 PMCID： PMC1498053 DOI： 10.1136/bmj.284.6324.1211-a

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

13 in total

1. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.

Authors: T S Herman; L H Einhorn; S E Jones; C Nagy; A B Chester; J C Dean; B Furnas; S D Williams; S A Leigh; R T Dorr; T E Moon
Journal: N Engl J Med Date: 1979-06-07 Impact factor: 91.245

2. Cannabis and cancer chemotherapy.

Authors: B M Colls
Journal: Lancet Date: 1980-05-31 Impact factor: 79.321

3. Bronchodilator effect of delta1-tetrahydrocannabinol.

Authors: J P Hartley; S G Nogrady; A Seaton
Journal: Br J Clin Pharmacol Date: 1978-06 Impact factor: 4.335

4. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.

Authors: H Ekert; K D Waters; I H Jurk; J Mobilia; P Loughnan
Journal: Med J Aust Date: 1979-12-15 Impact factor: 7.738

5. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.

Authors: V S Lucas; J Laszlo
Journal: JAMA Date: 1980-03-28 Impact factor: 56.272

6. The analgesic properties of delta-9-tetrahydrocannabinol and codeine.

Authors: R Noyes; S F Brunk; D A Avery; A C Canter
Journal: Clin Pharmacol Ther Date: 1975-07 Impact factor: 6.875

7. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.

Authors: B M Colls; D G Ferry; A J Gray; V J Harvey; E G McQueen
Journal: N Z Med J Date: 1980-06-25

8. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.

Authors: L E Orr; J F McKernan; B Bloome
Journal: Arch Intern Med Date: 1980-11

9. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.

Authors: S E Sallan; C Cronin; M Zelen; N E Zinberg
Journal: N Engl J Med Date: 1980-01-17 Impact factor: 91.245

10. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.

Authors: S Frytak; C G Moertel; J R O'Fallon; J Rubin; E T Creagan; M J O'Connell; A J Schutt; N W Schwartau
Journal: Ann Intern Med Date: 1979-12 Impact factor: 25.391

3 in total